“Visit was calm and enjoyable. Staff professional and friendly. Impressed with high-tech equipment. Wait minimal. Never felt rushed with the doctor.”
Anti-VEGF Injections: What Patients Need to Know About Treatment and Monitoring
Available Anti-VEGF Medications
Several anti-VEGF medications are available today, each with its own formulation and dosing profile. Our team selects the most appropriate option based on the specific condition, how the eye responds, and the patient's overall treatment needs.
A number of anti-VEGF drugs have been in clinical use for many years and have well-established safety and effectiveness records. Lucentis (ranibizumab) was the first anti-VEGF medication approved specifically for eye conditions. Eylea (aflibercept) became widely used and is typically given every four to eight weeks after an initial loading phase. Avastin (bevacizumab) is FDA-approved for cancer treatment but is commonly used off-label for retinal conditions, with large clinical trials supporting its effectiveness in many patients.
Newer medications have been developed with the goal of maintaining strong results while reducing how often patients need injections. Vabysmo (faricimab) works by targeting both VEGF and a second protein called angiopoietin-2, which also plays a role in abnormal blood vessel growth. This dual action can allow some patients to extend their injection intervals to every three or four months after initial loading doses.
Eylea HD delivers a higher concentration of aflibercept. After an initial monthly dosing phase, some patients may extend their visits to every eight to sixteen weeks. These extended-interval options can meaningfully reduce the overall treatment burden for qualifying patients.
Who Receives Anti-VEGF Treatment
Anti-VEGF injections are highly effective but are not appropriate for every patient or every type of retinal disease. Understanding who benefits most, and what risks exist, helps set realistic expectations from the start of treatment.
Patients whose retinal disease involves active abnormal blood vessel growth, fluid leakage, or macular swelling are typically candidates for anti-VEGF therapy. The severity of disease, the specific diagnosis, and prior treatment history all factor into the decision. No two cases of wet AMD, diabetic macular edema, or retinal vein occlusion are identical, so every treatment plan is individualized.
Anti-VEGF injections are generally very safe when performed by an experienced Retina Specialist using proper technique. However, as with any medical procedure, risks exist. The most serious potential complications include:
- Endophthalmitis, a severe eye infection that is rare but requires prompt treatment
- Sterile intraocular inflammation, a non-infectious reaction inside the eye
- Retinal detachment, a separation of the retina from the back of the eye
- Vitreous hemorrhage, or bleeding into the gel-filled space inside the eye
- Cataract development or progression
- Elevated intraocular pressure (IOP), which requires closer monitoring in patients who also have glaucoma
Our team discusses these risks with every patient before starting treatment and takes every precaution to minimize them at each visit.
Why Regular Monitoring Matters
Anti-VEGF treatment is not simply a series of routine injections. Each visit involves careful imaging and clinical assessment that directly guides treatment decisions. Staying consistent with monitoring appointments is just as important as receiving the injections themselves.
At Atlantic Retina Center, our team uses advanced retinal imaging at every visit to evaluate how the eye is responding to treatment. Optical coherence tomography, or OCT, is a non-invasive scan that produces detailed cross-section images of the retina. It allows our team to detect fluid, measure swelling, and track changes over time with great precision. Fluorescein angiography uses a specialized dye and camera to photograph blood flow and identify leaking vessels.
One of our core practices is comparing retinal photographs from visit to visit over time. This side-by-side comparison helps us detect even subtle changes before they progress, giving us the best opportunity to adjust treatment early.
There is no single injection schedule that works for every patient. Our Retina Specialists use individualized approaches to match the treatment plan to each person's needs. A common method called treat-and-extend gradually spaces injections further apart when imaging shows the retina is stable, then shortens the interval again if fluid returns. Another approach, sometimes called pro re nata or treat-and-observe, involves regular monitoring visits with injections given only when imaging shows active disease.
Both approaches aim to keep the retina as stable and fluid-free as possible while using the fewest injections needed. The right schedule depends on your specific condition and how your eye responds.
Research is clear that patients who miss or delay injections tend to have worse visual outcomes over time. Retinal fluid can return before you notice any change in your vision, meaning the damage may already be progressing by the time symptoms appear. Conditions like wet AMD, diabetic macular edema, and retinal vein occlusion often require treatment over months or even years, and gaps in care can allow lasting harm to develop.
Consistent follow-up is one of the most powerful things you can do to protect your vision. Even when your sight feels stable, your imaging may tell a different story.
Retina Specialists are ophthalmologists who have completed advanced fellowship training exclusively in diseases and surgery of the retina and vitreous. Our team is fellowship-trained and board-certified by the American Board of Ophthalmology, with the depth of experience needed to interpret OCT scans, read angiograms, and recognize early signs that a treatment plan needs to change.
Decisions about when to inject, when to extend intervals, when to switch medications, and when to consider additional treatments require nuanced clinical judgment. That judgment comes from dedicated specialty training and years of managing complex retinal disease.
What to Expect During Treatment
Many patients feel anxious about receiving injections into the eye. Understanding what actually happens during the procedure, and what the weeks and months of treatment look like, can make the experience far less intimidating.
Intravitreal injections are performed in the office and take only a few minutes from start to finish. The eye is first numbed with anesthetic drops so you do not feel sharp pain. The surface of the eye is cleaned with an antiseptic solution to minimize infection risk. Our Retina Specialist then uses a very fine needle to deliver the medication through the white of the eye (the sclera) into the vitreous cavity, the gel-filled interior of the eye.
Most patients feel pressure during the injection rather than pain. Some mild soreness, redness, or a gritty sensation may follow for a day or two. Small red spots on the white of the eye are common and typically resolve within a week or two.
Treatment typically begins with a loading phase of monthly injections for three consecutive months to build the medication's effectiveness. After that, the schedule depends on which medication is used and how your eye responds. With older anti-VEGF agents, some patients continue on a four-to-six-week cycle. With newer options like Vabysmo (faricimab) or Eylea HD, some patients qualify for intervals of every three to four months.
Even during extended intervals, monitoring visits between injections may be scheduled to confirm the retina remains stable. These check-in visits are an important part of keeping your care on track.
Retinal diseases are chronic, and your treatment needs can change over time. A medication that works well initially may become less effective, or imaging may reveal a reason to try a different approach. Our team continuously reassesses your retina at each visit and will recommend adjustments whenever the clinical picture calls for it. This ongoing relationship with your Retina Specialist is a cornerstone of preserving your long-term vision.
Warning Signs That Need Prompt Attention
While anti-VEGF treatment is generally very safe, certain symptoms after an injection, or at any time during the course of retinal disease, should never be ignored. Knowing what to watch for and when to act quickly can make a critical difference.
Mild discomfort and temporary redness are normal after an intravitreal injection. However, some symptoms may signal a serious complication and require immediate contact with your Retina Specialist. Reach out right away if you notice:
- Eye pain that increases or does not improve within a day of the injection
- Significant redness that worsens rather than improving
- A noticeable decrease in vision
- New or worsening floaters, flashes of light, or a shadow spreading across your vision
- Significant swelling of the eye or surrounding eyelid
These symptoms can be early signs of infection or other complications that require prompt evaluation and treatment.
Certain symptoms require urgent evaluation at any time, whether or not you have recently had an injection. A sudden increase in floaters, new flashes of light, a curtain or shadow moving across your vision, or sudden unexplained vision loss in one eye can indicate retinal detachment or another retinal emergency. If you experience any of these symptoms, seek care from a Retina Specialist or go to an emergency room immediately. Time is critical in preserving sight when a retinal emergency occurs.
Living With Ongoing Anti-VEGF Treatment
For many patients, anti-VEGF treatment continues over months or years. Managing the schedule, staying consistent with appointments, and working well with your care team are all part of getting the best long-term outcome.
Frequent office visits can be challenging, particularly for older patients or those with limited transportation options. Planning ahead helps. Scheduling several months of appointments at one time makes it easier to arrange transportation or take time away from work. Speaking openly with your Retina Specialist about any barriers you face is important, because adjustments to the regimen may be possible without compromising your care.
Attending every scheduled appointment is the single most important step you can take in protecting your vision. Retinal fluid can return quietly, without any noticeable change in what you see, and only imaging can detect that early recurrence. Missing even a few visits can allow disease activity to advance. If life circumstances cause you to miss an appointment, contact our office as soon as possible to reschedule rather than waiting for your next planned visit.
Your Retina Specialist works alongside your general ophthalmologist or optometrist. Your primary eye care provider may be the one who first identifies a retinal concern and refers you for specialized care. Once treatment begins, your other providers can continue managing glasses prescriptions and routine eye health. However, your Retina Specialist should remain the lead provider for all decisions related to your retinal condition, injections, and imaging-based monitoring.
Frequently Asked Questions
Patients often have practical questions that go beyond what is covered during a busy office visit. Here are answers to some of the most common.
There is no universal answer, because duration depends on your diagnosis and how your retina responds to treatment. Wet AMD and diabetic macular edema typically require long-term management, often measured in years rather than months. Some patients eventually reach a stable endpoint and can taper or discontinue injections, but this is a decision made carefully based on imaging and clinical judgment, not on how vision feels on a given day. Your Retina Specialist will discuss realistic expectations for your specific situation at each visit.
Switching medications is a well-established option when imaging shows that fluid persists or worsens despite regular treatment. Each anti-VEGF agent has a slightly different mechanism, and some patients respond better to one drug than another. If your current medication is not providing adequate control, your Retina Specialist may recommend trying Eylea, Vabysmo, or another agent in the class. This decision is guided by your imaging results and overall disease activity, not by symptoms alone.
Missing multiple appointments significantly increases the risk of vision loss. Retinal fluid can return and abnormal blood vessel activity can resume during a gap in treatment, often without any obvious change in your symptoms. Repeated episodes of fluid and leakage cause cumulative damage to retinal cells that cannot be reversed. If you have missed appointments, do not wait until your next scheduled visit. Contact our team as soon as possible so care can resume before further damage occurs.
The eye is thoroughly numbed before the injection, and most patients describe the sensation as pressure rather than sharp pain. Any soreness or irritation afterward is usually mild and resolves within a day or two. The idea of an injection near the eye is understandably uncomfortable for many people, but the vast majority of patients find that the procedure is much easier than they anticipated and becomes more routine after the first few visits.
For some patients, newer medications like Vabysmo (faricimab) or Eylea HD can provide effective disease control with longer intervals between injections, potentially every three to four months for qualifying patients. Whether an extended-interval approach is appropriate depends on how well your retina responds to treatment and which condition is being managed. Your Retina Specialist will evaluate your imaging at each visit and adjust the schedule based on what the retina needs, not on a fixed calendar.
Anti-VEGF therapy is most effective at stabilizing vision and preventing further loss. Some patients do experience meaningful improvement in visual acuity, particularly when treatment begins before extensive retinal damage has occurred. Vision that has been lost due to permanent scarring or photoreceptor damage is generally not recoverable. This is one of the key reasons early diagnosis and consistent treatment matter so much: the sooner active disease is controlled, the more vision there is to protect.
Schedule a Visit With Our Team
At Atlantic Retina Center, our fellowship-trained, board-certified Retina Specialists are dedicated exclusively to the diagnosis and treatment of retinal, vitreous, and macular disease. We proudly serve patients across the Eastern Shore of Maryland and central and southern Delaware with the focused expertise that complex retinal conditions require. If you have been referred for anti-VEGF treatment or have concerns about your retinal health, we encourage you to schedule a visit with our team and let us help you protect the vision you have.